GENPACT LIMITED vs STANTEC INC., two Consulting stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Genpact earns 23% on equity and 10.1% on assets; Stantec earns 14.8% and 6%. The better returns trade at the lower price, 8.8 times earnings against 22.4, because the market is pricing trajectories rather than levels: engineering backlog is expected to grow, outsourcing seats are expected to shrink under AI. Genpact meanwhile converts 13.6% of its price into free cash, among the highest yields in services, with a 2.4% dividend attached; Stantec yields 8% and pays none. The 13.6-turn multiple gap is a forecast about labor-based revenue models, and Genpact's page is where the forecast is cheapest to bet against.
Comparison updated 2026-07-10.
| Metric | G | STN |
|---|---|---|
| Price | $28.53 | $69.32 |
| Market cap | $4.9B | $7.9B |
| Sector | Consulting | Consulting |
| Stage | Mature | Growth |
| P/E | 8.8 | 22.4 |
| P/B | 1.99 | 3.32 |
| P/S | 0.96 | 1.32 |
| EV/EBITDA | 8.0 | — |
| Revenue growth | +6.4% | +15.6% |
| Gross margin | 36.4% | — |
| Operating margin | 15.3% | — |
| Net margin | 11.0% | 5.9% |
| Return on equity | 23.0% | 14.8% |
| Return on assets | 10.1% | 6.0% |
| Return on invested capital | 13.3% | — |
| FCF yield | 13.6% | 8.0% |
| Dividend yield | 2.4% | — |
| Debt / equity | 0.77 | 0.00 |
| Current ratio | 1.69 | 1.23 |
| Altman Z (solvency) | 2.54 | 2.47 |
| Piotroski F (quality) | 3 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.